Thomas Bachleitner‐Hofmann

3.9k citations
86 papers · 2.7k indexed · 1 hit paper · h-index 30
Topics
Breast Cancer Treatment Studies (12 papers)Immunotherapy and Immune Responses (11 papers)Colorectal Cancer Surgical Treatments (9 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Thomas Bachleitner‐Hofmann

83 papers receiving 2.7k citations

Hit Papers

Correlation of circular RNA abundance with proliferation ...20152026201820222015200400600

Peers

Thomas Bachleitner‐Hofmann
Comparison fields: 5 of 112
  • Molecular Biology 1.3k
  • Cancer Research 1.1k
  • Oncology 978
  • Immunology 438
  • Surgery 381
Replace Hiroko Bando with:
Hiroko Bando Japan
Yang Lü United States
Björn Erikstein Norway
Maccon Keane Ireland
Alison Joly United States
Dongfeng Tan United States
Xiaoqun Dong United States
Anne Hansen Ree Norway
Armand de Gramont France
Dimitrios Spentzos United States
Thomas Bachleitner‐Hofmann relative to Hiroko Bando Japan Hiroko Bando's profile →
Citations per field
00.5×1.5×
Hiroko Bando · 1×
Citations per year

Countries citing papers authored by Thomas Bachleitner‐Hofmann

Since Specialization
Citations

This map shows the geographic impact of Thomas Bachleitner‐Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bachleitner‐Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bachleitner‐Hofmann more than expected).

Fields of papers citing papers by Thomas Bachleitner‐Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bachleitner‐Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bachleitner‐Hofmann. The network helps show where Thomas Bachleitner‐Hofmann may publish in the future.

Co-authorship network of co-authors of Thomas Bachleitner‐Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bachleitner‐Hofmann. A scholar is included among the top collaborators of Thomas Bachleitner‐Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bachleitner‐Hofmann. Thomas Bachleitner‐Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 3
4 17
5 18
6 7
7 1
8 29
9 34
10 37
11 33
12 2
13 10
14 15
15 36
16 5
17 16
18 37
19 11
20 67

About Thomas Bachleitner‐Hofmann

Thomas Bachleitner‐Hofmann is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 86 papers that have together received 2.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Immunotherapy and Immune Responses (11 papers) and Colorectal Cancer Surgical Treatments (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (978 citations) and Immunology (438 citations). Thomas Bachleitner‐Hofmann has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Michael Gnant, Dietmar Pils, Agnes T. Reiner, Robert Zeillinger, Nyamdelger Sukhbaatar, Ildikó Mesteri, Anna Bachmayr-Heyda, R. Jakesz, Katharina Auer and Stefanie Aust. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026